journal
https://read.qxmd.com/read/38523905/extracorporeal-shockwave-therapy-of-the-perineum-for-male-patients-with-chronic-pelvic-pain-syndrome-a-pilot-study
#1
JOURNAL ARTICLE
Joe K C Lee, Terence Y X Law, Liang Shen, Gregory X W Pek, Qi Y Lim, Yi Q Tan, Jun Y Chia, Man K Li
BACKGROUND: Chronic pelvic pain syndrome (CPPS) is a complex condition that is often difficult to treat and may sometimes require a multidisciplinary team. Among the wide array of treatment options is extracorporeal shockwave therapy (ESWT). However, its role in CPPS remains controversial. The purpose of our study is to assess the efficacy and safety of ESWT of the perineum in male patients with CPPS. METHODS: Fourteen patients aged between 21 and 85 years were recruited in this single-center, single-arm prospective trial from October 2018 to October 2020...
March 2024: Prostate International
https://read.qxmd.com/read/38523904/infectious-complications-of-transrectal-prostate-biopsy-in-patients-receiving-targeted-antibiotic-prophylaxis-after-urethral-and-rectal-swab-versus-standard-prophylaxis-a-prospective-comparative-study
#2
JOURNAL ARTICLE
Sotirios Gatsos, Nikolaos Kalogeras, Georgios Dimakopoulos, Michael Samarinas, Anna Papakonstantinou, Efi Petinaki, Vassilios Tzortzis, Stavros Gravas
BACKGROUND: To evaluate the role of targeted antibiotic prophylaxis (TAP) after rectal and urethral swab cultures compared to empiric antibiotic prophylaxis (EAP) for the prevention of infectious complications after transrectal ultrasound-guided prostate biopsy (TRUS-Bx). METHODS: We conducted a prospective comparative study on 141 patients who underwent TRUS-Bx and were allocated in two groups. The first group (n = 71) received EAP with ciprofloxacin and the second (n = 70) received TAP according to rectal and urethral cultures...
March 2024: Prostate International
https://read.qxmd.com/read/38523903/prognosis-after-radical-prostatectomy-in-men-older-than-75%C3%A2-years-long-term-results-from-a-single-tertiary-center
#3
JOURNAL ARTICLE
Jaewon Lee, Jungkeun Song, Gyoohwan Jung, Sang Hun Song, Sung Kyu Hong
BACKGROUND: Despite longer lifespans, guidelines for prostate cancer treatment recommend surgery for those with over 10 years of life expectancy, potentially leaving older patients undertreated. This study examines the outcomes of radical prostatectomy (RP) in a large cohort of men older than 75 years. MATERIALS AND METHODS: We retrospectively analyzed 636 patients from a pool of 4,500 RP cases at a single tertiary institution from 2004 to 2022. Patients younger than 75 years or with incomplete records were excluded...
March 2024: Prostate International
https://read.qxmd.com/read/38523902/high-power-holmium-laser-versus-thulium-fiber-laser-for-endoscopic-enucleation-of-the-prostate-in-patients-with-glands-larger-than-80%C3%A2-ml-results-from-the-prostate-endoscopic-enucleation-study-group
#4
JOURNAL ARTICLE
Ee Jean Lim, Daniele Castellani, Bhaskar K Somani, Mehmet I Gökce, Khi Yung Fong, Fernando G Sancha, Thomas R W Herrmann, Sarvajit Biligere, Azimdjon N Tursunkulov, Marco Dellabella, Mario Sofer, Dmitry Enikeev, Vladislav Petov, Nariman Gadzhiev, Dean Elterman, Abhay Mahajan, Moises R Socarras, Dilmurod S Yunusov, Furkat Nasirov, Jeremy Y C Teoh, Vineet Gauhar
BACKGROUND: Endoscopic enucleation of the prostate (EEP) has gained acceptance as an equitable alternative to transurethral resection of the prostate for benign prostate hyperplasia (BPH). Our primary aim is to compare peri-operative outcomes of EEP using thulium fiber laser (TFL) against high-power holmium laser (HPHL) in hands of experienced surgeons for large prostates (≥80 ml in volume). Secondary outcomes were assess complications within 1 year of follow up. MATERIALS AND METHODS: We retrospectively reviewed patients with benign prostatic hyperplasia who underwent EEP with TFL or HPHL in 13 centers (January 2019-January 2023)...
March 2024: Prostate International
https://read.qxmd.com/read/38523901/a-novel-anterior-approach-that-involves-retzius-space-development-between-the-umbilical-ligaments-is-associated-with-a-lower-incidence-of-postoperative-inguinal-hernia-in-robotic-radical-prostatectomy
#5
JOURNAL ARTICLE
Satoshi Washino, Shozaburou Mayumi, Kimitoshi Saito, Kai Yazaki, Yuhki Nakamura, Tomoaki Miyagawa
BACKGROUND: To facilitate robotic radical prostatectomy (RP), we developed a novel anterior approach that utilizes a peritoneal incision between the umbilical ligaments to develop the Retzius space without contacting the internal inguinal rings, followed by closure of this space prior to prostatectomy and vesicourethral anastomosis. This approach could decrease the incidence of postoperative inguinal hernia (IH), similar to a Retzius-sparing RP (RS-RP). We compared the incidence of IH following this novel approach with that following conventional anterior RP and RS-RP...
March 2024: Prostate International
https://read.qxmd.com/read/38523900/real-world-effects-of-novel-androgen-receptor-axis-targeted-agents-on-oncological-outcomes-in-non-metastatic-castration-resistant-prostate-cancer-a-multi-institutional-retrospective-study
#6
JOURNAL ARTICLE
Naoki Fujita, Shingo Hatakeyama, Ryuji Tabata, Kazutaka Okita, Koichi Kido, Itsuto Hamano, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Yuichiro Suzuki, Takahiro Yoneyama, Yasuhiro Hashimoto, Satoshi Sato, Chikara Ohyama
BACKGROUND: The benefits of novel androgen receptor axis-targeted agents (ARATs) on oncological outcomes in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in real-world settings are unclear. METHODS: This multi-institutional retrospective study included 178 patients with nmCRPC treated between September 2003 and August 2022. Patients were divided into two groups: those who were treated with any novel ARATs, including apalutamide, enzalutamide, darolutamide, and abiraterone acetate, during any line of nmCRPC treatment (novel ARATs group) and those who were not (control group)...
March 2024: Prostate International
https://read.qxmd.com/read/38523899/shifting-to-transperineal-prostate-biopsy-a-narrative-review
#7
REVIEW
Younsoo Chung, Sung Kyu Hong
To address the limitations and challenges associated with transrectal (TR) biopsy and to present transperineal (TP) biopsy as a viable and potentially safer alternative to TR biopsy. Prostate cancer (PCa) is a significant global health concern. The prevalence of advanced-stage prostate cancer in Asia is higher than that in the United States, emphasizing the need for effective screening and diagnosis methods. The gold standard of diagnosis is a TR biopsy. However, it has limitations due to the risk of infection and potential complications, such as injury to the rectal artery...
March 2024: Prostate International
https://read.qxmd.com/read/38523898/prostate-cancer-nomograms-and-their-application-in-asian-men-a-review
#8
REVIEW
Sridhar Panaiyadiyan, Rajeev Kumar
Nomograms help to predict outcomes in individual patients rather than whole populations and are an important part of evaluation and treatment decision making. Various nomograms have been developed in malignancies to predict and prognosticate clinical outcomes such as severity of disease, overall survival, and recurrence-free survival. In prostate cancer, nomograms were developed for determining need for biopsy, disease course, need for adjuvant therapy, and outcomes. Most of these predictive nomograms were based on Caucasian populations...
March 2024: Prostate International
https://read.qxmd.com/read/38523897/real-world-prostate-specific-antigen-reduction-and-survival-outcomes-of-metastatic-hormone-sensitive-prostate-cancer-patients-treated-with-apalutamide-an-observational-retrospective-and-multicentre-study
#9
JOURNAL ARTICLE
Alicia López-Abad, Miguel Ramírez Backhaus, Gerardo Server Gómez, Enrique Cao Avellaneda, Cristóbal Moreno Alarcón, Pedro López Cubillana, Pablo Yago Giménez, Pedro de Pablos Rodríguez, María J Juan Fita, Miguel Á Climent Durán, Iris Guardiola Ruiz, Natalia Vidal Crespo, Miriam Artés Artés, Raúl Montoya Chinchilla, Juan Moreno Avilés, Pablo L Guzmán Martínez-Valls, Pedro Á López González
BACKGROUND: Metastatic hormone-sensitive prostate cancer (mHSPC) treatment has changed drastically during the last years with the emergence of androgen receptor-targeted agents (ARTAs). ARTA combined with androgen deprivation therapy has demonstrated better oncological and survival outcomes in these patients. However, the optimal choice among different ARTAs remains uncertain due to their analogous efficacy. OBJECTIVES: The objective of this study was to describe prostate-specific antigen (PSA) response and oncological outcomes of patients with mHSPC treated with apalutamide...
March 2024: Prostate International
https://read.qxmd.com/read/38196558/prostate-specific-antigen-doubling-time-predicts-the-efficacy-of-site-directed-therapy-for-oligoprogressive-castration-resistant-prostate-cancer
#10
JOURNAL ARTICLE
Taketo Kawai, Satoru Taguchi, Keina Nozaki, Naoki Kimura, Takahiro Oshina, Takuya Iwaki, Hotaka Matsui, Aya Niimi, Jun Kamei, Yoshiyuki Akiyama, Yuta Yamada, Yusuke Sato, Daisuke Yamada, Tomoyuki Kaneko, Subaru Sawayanagi, Hidetsugu Nakayama, Ryogo Minamimoto, Hideomi Yamashita, Hideyo Miyazaki, Tetsuya Fujimura, Tohru Nakagawa, Haruki Kume
BACKGROUND: In recent years, site-directed therapies (SDTs) targeting progressive lesions in patients with oligometastatic prostate cancer have attracted attention. However, whether they effectively treat oligoprogressive castration-resistant prostate cancer (CRPC) remains unclear. Here, we investigated the efficacy of SDT in patients with oligoprogressive CRPC and identified prognostic factors. METHODS: We reviewed 59 patients with oligoprogressive CRPC who underwent SDT targeting prostate or metastatic lesions between April 2014 and March 2022...
December 2023: Prostate International
https://read.qxmd.com/read/38196557/the-feasibility-of-distance-to-the-tumor-of-biopsy-cores-to-estimate-the-extracapsular-extension
#11
JOURNAL ARTICLE
Chang Lim Hyun, Kyung Kgi Park
BACKGROUND: To investigate the predictive capability of a new parameter, the distance between the fibromuscular capsule and the tumor as measured using a prostate biopsy core (referred to as "distance to the tumor" [DTT]), for the presence of extracapsular extension (ECE). MATERIALS AND METHODS: We analyzed specimens obtained from 246 patients diagnosed with prostate cancer. All patients underwent prebiopsy, prostate magnetic resonance imaging (MRI), and subsequent prostatectomy...
December 2023: Prostate International
https://read.qxmd.com/read/38196556/safety-and-efficacy-of-tamsulosin-0-4%C3%A2-mg-as-an-initial-dose-in-1-219-korean-patients-with-moderate-to-severe-lower-urinary-tract-symptoms-data-from-a-phase-iv-study
#12
JOURNAL ARTICLE
Jun Ho Lee, Yeon Won Park, Moon-Hwa Park, Tag Keun Yoo
BACKGROUND: An initial dose of tamsulosin 0.2 mg is frequently prescribed for Asian men. We investigated the safety and efficacy of tamsulosin 0.4 mg as the initial dose in Korean men with moderate to severe lower urinary tract symptoms (LUTSs) in everyday clinical practice. MATERIALS AND METHODS: A phase IV study was conducted in South Korea. Eligible patients were prescribed tamsulosin 0.4 mg for 6 months. We excluded patients with previous exposure to LUTS drugs and patients with an international prostate symptom score (IPSS) < 8...
December 2023: Prostate International
https://read.qxmd.com/read/38196555/detection-of-anterior-prostate-cancer-using-a-magnetic-resonance-imaging-transrectal-ultrasound-fusion-biopsy-in-cases-with-initial-biopsy-and-history-of-systematic-biopsies
#13
JOURNAL ARTICLE
Masakazu Abe, Ryo Takata, Daiki Ikarashi, Kie Sekiguchi, Daichi Tamura, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Takashi Ujiie, Wataru Obara
BACKGROUND: Prostate cancer in the anterior region may be missed on a transrectal systematic biopsy (SBx). Therefore, this study aimed to evaluate the performance of magnetic resonance imaging-transrectal ultrasound (MRI-TRUS) fusion targeted biopsy (TBx) in detecting anterior region cancer in patients with a history of SBxs. METHODS: Prostate biopsies were performed in 224 patients after multiparametric MRI, among whom 119 patients with prostate imaging reporting and data system (PI-RADS version 2) scores of 3 to 5 underwent MRI-TRUS fusion TBxs...
December 2023: Prostate International
https://read.qxmd.com/read/38196554/reviving-intimacy-penile-rehabilitation-strategies-for-men-after-prostate-cancer-treatment
#14
REVIEW
James Stinson, Nelson Bennett
There have been considerable advances in the field of penile rehabilitation for upwards of 90% of men adversely affected by either short-term or long-term erectile dysfunction after definitive prostate cancer treatment. Despite the evolving landscape of treatment modalities for penile rehabilitation, there is a lack of consensus in the urologic community on the best therapies due to the level of evidence and efficacies of the current and emerging offerings. This review of current and next-generation interventions provides a practical approach to the myriad of data to make a better-informed decision based on the pathophysiology and highest-quality evidence available...
December 2023: Prostate International
https://read.qxmd.com/read/38196553/-cervi-parvum-cornu-complex-for-men-with-lower-urinary-tract-symptoms-a-multicenter-randomized-double-blind-placebo-controlled-trial
#15
JOURNAL ARTICLE
Dongho Shin, Byung Il Yoon, Soomin Kim, JunJie Piao, Kyung-Hwa Jeon, Youngjoo Kwon, Sang-Hyuck Park, Young Tae Koo, Jin-Soo Kim, Dong Sup Lee, U-Syn Ha, Sae Woong Kim, Hoon Jang, Woong Jin Bae
BACKGROUND: To evaluate the efficacy and safety of Cervi Parvum Cornu , Angelicae Gigantis Radix and Glycyrrhizae Radix complex (CAG) in men with moderate lower urinary tract symptoms (LUTS). MATERIALS AND METHODS: From November 2020 to January 2022, participants with International Prostate Symptom Score (IPSS) of 12-19 in two centers were recruited and randomize into three groups: a CAG 500 mg/day group (CAG 500), a CAG 1000 mg/day group (CAG 1000), and a placebo group (PG)...
December 2023: Prostate International
https://read.qxmd.com/read/38196552/single-port-and-multiport-robot-assisted-radical-prostatectomy-a%C3%A2-meta-analysis
#16
REVIEW
Tuan Thanh Nguyen, Ryan W Dobbs, Huy Gia Vuong, Khoa Quy, Hanh Thi Tuyet Ngo, Anh Tuan Mai, Mai Tran Thi Tuyet, Minh Sam Thai, Ho Yee Tiong, Se Young Choi, Mohammed Shahait, David I Lee
OBJECTIVE: To compare the perioperative, oncological, and functional outcomes between single-port robot-assisted radical prostatectomy (SP-RARP) and multiport robot-assisted radical prostatectomy (MP-RARP) via a meta-analysis. METHODS: For relevant articles, three electronic databases, including PubMed, Scopus, and Web of Science, were searched from their inception until January 15, 2022. A meta-analysis has been reported in line with PRISMA 2020 and AMSTAR Guidelines...
December 2023: Prostate International
https://read.qxmd.com/read/38196551/artificial-intelligence-in-urologic-oncology-the-actual-clinical-practice-results-of-ibm-watson-for-oncology-in-south-korea
#17
JOURNAL ARTICLE
Taeyoung Park, Philip Gu, Chang-Hee Kim, Kwang Taek Kim, Kyung Jin Chung, Tea Beom Kim, Han Jung, Sang Jin Yoon, Jin Kyu Oh
BACKGROUND: Artificial intelligence (AI) is changing our life, including the medical field. Repeated machine learning using big data made various fields more predictable and accurate. In medicine, IBM Watson for Oncology (WFO), trained by Memorial Slone Kettering Cancer Center (MSKCC), was first introduced and applied in 14 countries worldwide.Our study was designed to assess the feasibility of WFO in actual clinical practice. We aimed to investigate the concordance rate between WFO and multidisciplinary tumor board (MTB) in Urologic cancer patients...
December 2023: Prostate International
https://read.qxmd.com/read/38196550/evaluation-of-the-efficiency-of-transurethral-enucleation-with-bipolar-energy-according-to-prostate-volume-for-patients-with-benign-prostate-hyperplasia
#18
JOURNAL ARTICLE
Byeongdo Song, Sang Hun Song, Seong Jin Jeong
BACKGROUND: This study evaluated the efficiency and safety of transurethral enucleation with bipolar energy (TUEB) using a spatula loop according to prostate volume. METHODS: We retrospectively evaluated 398 patients who underwent TUEB for benign prostatic hyperplasia at a single tertiary hospital between August 2018 and December 2022. The patients were divided into three groups according to estimated prostate volume (ePV): ≤40 mL (n = 67), 40-80 mL (n = 200), and ≥80 mL (n = 131)...
December 2023: Prostate International
https://read.qxmd.com/read/37745911/the-oncologic-and-safety-outcomes-of-low-dose-rate-brachytherapy-for-the-treatment-of-prostate-cancer
#19
REVIEW
Nobumichi Tanaka
Around 40 years have passed since a modern low-dose-rate (LDR) brachytherapy for prostate cancer was introduced. LDR brachytherapy has become one of the definitive treatment options besides radical prostatectomy (RP) and external beam radiation therapy (EBRT). LDR brachytherapy has several advantages over EBRT such as a higher prescribed dose to the prostate gland while avoiding unnecessary irradiation of organs at risk, a precipitous dose gradient, a brief treatment time, and a short hospital stay. Previous reports revealed that the long-term oncologic outcomes of LDR brachytherapy are superior to those of EBRT...
September 2023: Prostate International
https://read.qxmd.com/read/37745910/predictive-factors-for-disease-progression-after-salvage-radiation-therapy-in-biochemical-recurrent-patients-treated-by-radical-prostatectomy
#20
JOURNAL ARTICLE
Koichi Aikawa, Shoji Kimura, Fumihiko Urabe, Kosuke Iwatani, Kojiro Tashiro, Atsuhiko Ochi, Hirokazu Abe, Manabu Aoki, Takahiro Kimura
OBJECTIVE: Salvage radiation therapy (SRT) is standard treatment for patients after radical prostatectomy (RP). However, the optimal timing of SRT remains to be elucidated. MATERIAL AND METHODS: We retrospectively reviewed 133 prostate cancer (PCa) patients who underwent SRT for biochemical recurrence after RP. Disease progression was defined as repeated prostate-specific antigen (PSA) level more than 0.2 ng/mL, greater than the post-SRT nadir or radiographic progression...
September 2023: Prostate International
journal
journal
47870
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.